JB Pharma inks Rs 964-cr licence deal with Novartis for ophthalmology brands

JB Pharma inks Rs 964-cr licence deal with Novartis for ophthalmology brands As per IQVIA, MAT September, 2023 data, sales for these brands was at Rs 207.8 Crores.

from Moneycontrol Business News https://ift.tt/osxlIfN
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...